| XLS |
|
|
|
|
|
|
|
€ million |
Q3 – 2014 |
Q3 – 2013 |
Jan.–Sept. 2014 |
Jan.–Sept. 2013 |
|
Profit after tax |
249.6 |
342.5 |
883.0 |
927.6 |
|
Items of other comprehensive income that will not be reclassified to profit or loss in subsequent periods: |
|
|
|
|
|
Remeasurement of the net defined benefit liability |
|
|
|
|
|
Changes in remeasurement |
–171.3 |
25.2 |
–416.5 |
–18.3 |
|
Deferred taxes |
27.3 |
–4.0 |
72.4 |
2.7 |
|
Changes recognized in equity |
–144.0 |
21.2 |
–344.1 |
–15.6 |
|
|
–144.0 |
21.2 |
–344.1 |
–15.6 |
|
Items of other comprehensive income that may be reclassified to profit or loss in subsequent periods: |
|
|
|
|
|
Available-for-sale financial assets |
|
|
|
|
|
Fair value adjustments |
–1.1 |
0.8 |
–2.2 |
1.6 |
|
Reclassification to profit or loss |
– |
– |
1.7 |
– |
|
Deferred taxes |
– |
–0.1 |
–0.1 |
–0.6 |
|
Changes recognized in equity |
–1.1 |
0.7 |
–0.6 |
1.0 |
|
Derivative financial instruments |
|
|
|
|
|
Fair value adjustments |
144.8 |
37.6 |
92.3 |
81.3 |
|
Reclassification to profit or loss |
–9.0 |
–8.2 |
–35.3 |
–13.1 |
|
Reclassification to assets |
– |
– |
– |
– |
|
Deferred taxes |
–17.6 |
–8.8 |
1.5 |
–16.0 |
|
Changes recognized in equity |
118.2 |
20.6 |
58.5 |
52.2 |
|
Exchange differences on translating foreign operations |
|
|
|
|
|
Changes taken directly to equity |
359.3 |
–61.2 |
448.4 |
–138.6 |
|
Reclassification to profit or loss |
– |
– |
– |
–7.6 |
|
Changes recognized in equity |
359.3 |
–61.2 |
448.4 |
–146.2 |
|
|
476.4 |
–39.9 |
506.3 |
–93.0 |
|
Other comprehensive income |
332.4 |
–18.7 |
162.2 |
–108.6 |
|
Comprehensive income |
582.0 |
323.8 |
1,045.2 |
819.0 |
|
of which attributable to Merck KGaA shareholders |
578.5 |
324.9 |
1,034.8 |
820.0 |
|
of which attributable to non-controlling interests |
3.5 |
–1.1 |
10.4 |
–1.0 |
back
